文献速递腹部CT

基于影像组学的胃癌HER2状态与预后评估:一项回顾性双中心CT研究

Radiomics-based assessment of HER2 status and prognosis in gastric cancer: a retrospective dual-center CT study.
PubMed 文献 · Abdom Radiol (NY) · 2025-04-08

这项回顾性双中心研究纳入431例胃癌患者,构建基于CT影像组学评分联合性别和CA72-4的列线图预测HER2状态。列线图在训练、测试和外部验证队列的AUC分别为0.847、0.836和0.828,决策曲线分析显示其净获益更高。列线图预测HER2阳性的患者总生存期显著更短。

要点

  • 基于CT影像组学评分联合性别和CA72-4的列线图可无创预测术前HER2状态,外部验证AUC为0.828。
  • 列线图预测HER2阳性的患者总生存期显著更短,可用于预后风险分层。
  • 影像组学模型单独预测HER2状态的外部验证AUC为0.784。

核心结论

  • 基于CT的影像组学列线图能够无创预测该胃癌队列的术前HER2状态并进行预后风险分层。

研究设计与样本

  • 回顾性双中心研究,纳入431例胃癌患者,分为训练队列221例、测试队列94例和外部验证队列116例,基于CT影像组学特征和临床变量构建影像组学模型及列线图,以受试者工作特征曲线下面积评估预测准确性。

诊断标准与关键数值

  • 影像组学模型预测HER2状态在训练、测试和外部验证队列的AUC分别为0.801、0.793和0.784。
  • 整合性别、CA72-4水平和影像组学评分的列线图预测HER2状态在训练、测试和外部验证队列的AUC分别为0.847、0.836和0.828。

临床应用与阅片要点

  • 决策曲线分析显示列线图能提供更高的净获益,具有临床实用性。
  • 列线图预测HER2阳性的患者总生存期显著更短,可提供风险分层和预后信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: This research investigated the potential of CT-based radiomics analysis for predicting human epidermal growth factor receptor 2 (HER2) status and assessing the prognosis of patients with gastric cancer (GC).

METHODS: 431 patients with GC from two medical centers were included in this retrospective study, with patients allocated to a training cohort (n = 221), a testing cohort (n = 94), and an external validation cohort (n = 116). Radiomics features and clinical variables associated with HER2 status were identified, and the radiomics score was subsequently derived. A radiomics model was constructed using the radiomics score, and a nomogram was developed by integrating related variables. The predictive accuracy of models was assessed via receiver operating characteristic curves, with the area under the curve (AUC) being computed. Prognostic significance was assessed by exploring the association between nomogram-predicted HER2 status and overall survival (OS).

RESULTS: The radiomics model yielded AUCs of 0.801, 0.793, and 0.784 for the training, testing, and external validation cohorts, respectively. A nomogram that integrated sex, CA72-4 levels, and radiomics score exhibited enhanced predictive accuracy, achieving AUCs of 0.847, 0.836, and 0.828 across the cohorts. Decision curve analysis highlighted the clinical utility of the nomogram, illustrating its ability to deliver a higher net benefit. In addition, survival analysis indicated that individuals with nomogram-predicted HER2 positivity experienced significantly shorter OS, providing robust risk stratification and prognostic insights.

CONCLUSION: The CT-based radiomics nomogram demonstrated the ability to non-invasively predict preoperative HER2 status and stratify prognostic risk in this GC cohort.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Li M, Jiang S, Zhou S, et al. Radiomics-based assessment of HER2 status and prognosis in gastric cancer: a retrospective dual-center CT study. Abdom Radiol (NY). 2025. PMID: 40195138. doi:10.1007/s00261-025-04912-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。